Safety and Efficacy of the Lentiviral Vector in Gene Therapy of Beta-thalassemia Patients

Conditions: Transfusion-dependent Beta-Thalassemia Interventions: Genetic: KL003 cell injection Drug Product Sponsors: Institute of Hematology& Blood Diseases Hospital, China; Kanglin Biotech Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials